Additional evidence for the dampening roles of TREM-2 comes from recent studies in which TREM-2 was shown to suppress EAE, the mouse model of MS (11, 12), and to promote colonic wound healing through increased production of the anti-inflammatory cytokines IL-4 and IL-13 in the wound bed (13). Here, TREM2 is linked to myeloid sarcoma.